Technology News and Research

RSS

TU Delft's nuclear research to be used for producing medical isotopes

TU Delft's nuclear research reactor will be used as a back-up facility for the production of the radioactive isotope molybdenum-99, when supplies run out. Molybdenum-99 is widely used in hospitals in order to locate cancer.

27 Sep 2010

Americans eating fewer vegetables and getting fatter

Despite two decades of public health initiatives, stricter government dietary guidelines, record growth of farmers' markets and the ease of products like salad in a bag, Americans still aren't eating enough vegetables. This month, the Centers for Disease Control and Prevention issued a comprehensive nationwide behavioral study of fruit and vegetable consumption.

27 Sep 2010

Stirling Products’ drug delivery technology interests big ‘pharma’

Healthcare group, Stirling Products Limited (ASX:STI) has advised that following the recent TeleMedCare e-health acquisition and the conditional addition of the recently announced pathology business (subject to due diligence completion and shareholder approval), the Company is now in process of its strategised business integration.

26 Sep 2010

Navilyst Medical to distribute VasoNova's VPS central venous catheter navigation technology

VasoNova announced a strategic partnership with Navilyst Medical Inc. today to distribute its VasoNova™ Vascular Positioning System™ VPS™ central venous catheter navigation technology.

24 Sep 2010

Task of catastrophe data collection in hands of ordinary citizens

The National Science Foundation has awarded a $65,000 grant to a newly hired Virginia Tech College of Engineering assistant professor who wants to put the task of data collection during a catastrophe such as the recent Gulf Coast oil spill into the hands of ordinary citizens.

24 Sep 2010

Origin Biotechnology reaches worldwide agreement with Chinese Academy of Agricultural Sciences for Bt-gene

Origin Biotechnology, a wholly-owned subsidiary of Origin Agritech Limited announced it has reached an comprehensive, worldwide agreement with the Institute of Plant Protection, Chinese Academy of Agricultural Sciences (CAAS). CAAS jointly own the rights to the internally developed Bt-gene.

24 Sep 2010

OrbusNeich completes enrollment in Combo Bio-engineered Sirolimus Eluting Stent clinical trial

OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.

24 Sep 2010

SurgiCount Safety-Sponge System reduces retained surgical sponges

SurgiCount Medical, the wholly-owned operating subsidiary of Patient Safety Technologies, Inc. announced that results of independent, unsponsored clinical research conducted by the Mayo Clinic on their multi-year effort to reduce retained foreign objects will be presented and discussed at two upcoming conferences.

24 Sep 2010

NSBRI project to develop LTM/iRevive system for astronauts’ medical care

On an exploration mission, an astronaut has an accident and appears to have serious injuries as the spacecraft speeds to its destination. The ensuing scene is hectic as the other crew members try to get a grasp on the situation and provide appropriate treatment. Efficient use of time and resources may be the difference between life and death.

24 Sep 2010

Six Chicago high school students win CAP's 2010 'Path to a Future in Medicine' award

The College of American Pathologists (CAP) awarded six Chicago high school students the College's 2010 "Path to a Future in Medicine" award.

24 Sep 2010

Progress in realizing potential of satellite measurements of air pollution

In many developing countries, the absence of surface-based air pollution sensors makes it difficult, and in some cases impossible, to get even a rough estimate of the abundance of a subcategory of airborne particles that epidemiologists suspect contributes to millions of premature deaths each year. The problematic particles, called fine particulate matter (PM2.5), are 2.5 micrometers or less in diameter, about a tenth the fraction of human hair. These small particles can get past the body's normal defenses and penetrate deep into the lungs.

24 Sep 2010

Efforts to reduce worker exposure to hazards during disaster response, cleanup

The National Institute of Environmental Health Sciences (NIEHS) is awarding $36 million in grants to 20 organizations that develop safety and health training for workers involved in hazardous waste operations and transportation, environmental restoration of contaminated facilities, and chemical emergency response. These training programs can receive annual funding for up to five years.

24 Sep 2010

Aortic stent graft market in Latin America to expand to over $150M by 2015

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, Latin American physicians will increasingly adopt abdominal and thoracic endovascular aortic repair in place of surgical repair through 2015 as awareness of the benefits of endovascular techniques grows and physician training improves.

24 Sep 2010

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Cerus Corporation announced today that it has received an additional $1.4 million from the U.S. Department of Defense to support advanced development of the company's pathogen inactivation technology for red blood cells. The INTERCEPT red blood cell system is a pathogen inactivation product Cerus is developing to prevent the transmission of infectious diseases through red blood cell transfusions.

24 Sep 2010

Pres. Obama unveils new U.S. Global Development Policy at U.N. MDGs summit

During a U.N. Summit on the Millennium Development Goals address in New York on Wednesday, President Barack Obama outlined "changes in how the United States will pursue international development" and "urged wealthy countries ... to maintain development assistance to poor nations," the Washington Post reports.

24 Sep 2010

FDA designates AMT-080 gene therapy for Duchenne muscular dystrophy

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the field of human gene therapy, announced today that the U.S. Food and Drug Administration (FDA) has designated AMT-080, a gene therapy for Duchenne muscular dystrophy (DMD) as an orphan drug.

24 Sep 2010

Insurers face barrage of challenges in overhaul's rollout

The first big wave of new rules under the federal health care law goes into effect on Thursday, leaving many insurers scrambling to get ahead of the changes. Insurers are cutting administrative staff to lower overhead costs, investing in big technology upgrades and training employees to field the expected influx of customer inquiries.

24 Sep 2010

NeoStem signs merger agreement to acquire Progenitor Cell Therapy

NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.

24 Sep 2010

Advitech completes UVA testing study on oleosome sunscreen formulation

Advitech Inc. is pleased to announce today that a key UVA testing study has been completed on its oleosome-based sunscreen prototype formulation.

24 Sep 2010

Researchers to develop vitamin D producing fluorescent lamp for fat malabsorption syndromes

Boston University School of Medicine (BUSM) researchers have been awarded a Small Business Technology Transfer (STTR) phase 1 award to develop and test a newly designed fluorescent lamp that is capable of producing vitamin D in the skin.

24 Sep 2010